Intellia Therapeutics, Inc. (NTLA)
15.90
+1.87
(+13.33%)
USD |
NASDAQ |
Jan 22, 16:00
15.94
+0.04
(+0.25%)
After-Hours: 20:00
Intellia Therapeutics Cash from Investing (Quarterly): -0.741M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 65.66M |
| ANI Pharmaceuticals, Inc. | -6.163M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Pacific Biosciences of California, Inc. | 18.90M |
| Twist Bioscience Corp. | -12.40M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -76.90M |
| Cash from Financing (Quarterly) | 114.86M |
| Free Cash Flow | -412.63M |
| Free Cash Flow Per Share (Quarterly) | -0.6982 |
| Free Cash Flow to Equity (Quarterly) | -72.30M |
| Free Cash Flow to Firm (Quarterly) | -76.93M |
| Free Cash Flow Yield | -24.76% |